SCUBE3 and cancer: Our data were consistent with most previous studies reported in other cancer types including NSCLC [14], osteosarcoma [28], and renal cell carcinoma [29], which suggested that high SCUBE3 expression may be a universal indicator of poorer prognosis in cancers (Additional file 2).